RecruitingPhase 1NCT05241444
CD4^LVFOXP3 in Participants With IPEX
Studying Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bacchetta, Rosa, MD
- Principal Investigator
- Jessie Alexander, MDStanford University
- Intervention
- CD4^LVFOXP3(biological)
- Enrollment
- 30 enrolled
- Eligibility
- 35 years · MALE
- Timeline
- 2022 – 2037
Study locations (1)
- Lucile Packard Children's Hospital, Palo Alto, California, United States
Collaborators
California Institute for Regenerative Medicine (CIRM)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05241444 on ClinicalTrials.gov